Locations:
Search IconSearch
December 12, 2017/Neurosciences

Surgeons Collaborate to Remove Intraorbital Hemangioma (Video)

Head & neck surgeon and neurosurgeon perform complex endonasal procedure

17-ENT-4469-Recinos-Hero-Image-650x450pxl

Endoscopic sinus and skull base surgeon Raj Sindwani, MD, and neurosurgeon Pablo Recinos, MD, partner on complex endoscopic skull base surgeries that rely on a “two surgeons, four hands” simultaneous approach rather than the tag-team approach of traditional endonasal pituitary surgery.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

These procedures have proliferated greatly since 2014 with the launch of Cleveland Clinic’s Minimally Invasive Cranial Base and Pituitary Surgery Program, a multidisciplinary collaboration between Cleveland Clinic’s Head & Neck Institute and the Neurological Institute’s Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center.

Given the success of the two-surgeon approach, the team now routinely employs its expertise for the management of other complex pathologies located in hard to reach areas of the head. Dr. Sindwani and Dr. Recinos recently used an endoscopic, endonasal approach for resection of an intraorbital/orbital apex l hemangioma for a patient who was having severe progressive vision loss due to the mass. This was a challenging procedure due to the deep location of the tumor within the intraconal space of the eye, and because of its close proximity to the optic nerve. They selected the safest endoscopic corridor to approach the tumor (between the inferior and medial rectus muscles) and removed the mass without any cuts or bruises. The patient’s vision was restored to normal.

See how the tumor was removed and learn more about the patient’s amazing outcome in this video showing step by step how the procedure was done.

Advertisement

Related Articles

Portrait of Dr. Margolius
October 16, 2025/Neurosciences/Podcast
Genetics: The Cause and a Cause for Hope in Huntington’s Disease (Podcast)

Gene-based treatments could be the future for neurodegenerative condition

older man at a table with younger man handing him pill containers
October 15, 2025/Neurosciences/Brain Health
Real-World Data Suggest Two Antidiabetic Drug Classes May Curb Alzheimer’s Risk

Observational evidence of neuroprotection with GLP-1 receptor agonists and SGLT-2 inhibitors

Two people working in a community garden
Rehabilitation: Beyond Recovery, Toward Renewed Participation

Tasked-based therapy improves social connection and quality of life

gloved hand holding blood vial with neuropathology slide in background
October 10, 2025/Neurosciences/Epilepsy
Blood-Based Epigenetic Biomarkers Differentiate Focal Cortical Dysplasia Subtypes

Paired blood and brain tissue methylation findings raise prospect of noninvasive precision diagnosis

young man using walking canes on a city street
Vidofludimus for Progressive MS: No Impact on Brain Atrophy but Hints of a Role for Disability

Mixed results from phase 2 CALLIPER trial of novel dual-action compound

illustration of myelin sheaths wrapped around neuron axons
Revised McDonald Criteria for Multiple Sclerosis: A Big Step Toward Biomarker-Driven Diagnosis

A co-author of the new recommendations shares the updates you need to know

Dr. Jason Savage against a decorative background with podcast button overlay
October 2, 2025/Neurosciences/Podcast
Essentials of Revision Spine Deformity Surgery (Podcast)

Success for these complex operations requires judicious patient selection and presurgical patient optimization

physician talking with a patient in medical office
De-Escalation of Disease-Modifying Therapies in MS: A Real-World Look at Outcomes

Rebound risk is shaped by patient characteristics and mechanism of action of current DMT

Ad